Dolby Laboratories, Inc. (DLB) insider trading.
In Q3 2026, insiders at Dolby Laboratories, Inc. reported 16 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $1.7M.
- Transactions
- 16
- Purchases (P)
- 0
- Sales (S)
- 8
- Net shares, P minus S
- -28,889
- Insiders
- 6
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Couling John D | Officer · SVP, Entertainment | 8 | 0 | 4 |
| Nicholson Ryan | Officer · VP, CAO and Corp. Controller | 3 | 0 | 3 |
| DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 / Dolby Dagmar | TenPercentOwner | 2 | 0 | 0 |
| Sherman Mark Andrew | Officer · EVP, Gen. Counsel & Secretary | 1 | 0 | 0 |
| Whitten Marc | Director, Officer · President and CEO | 1 | 0 | 0 |
| Revankar Shriram | Officer · SVP, Advanced Technology Group | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sherman Mark Andrew | A (A) | 48,076 | $0 | 119,024 | Form 4 |
| 2026-09-15 | Couling John D | A (A) | 48,076 | $0 | 166,803 | Form 4 |
| 2026-09-15 | Whitten Marc | A (A) | 160,256 | $0 | 160,256 | Form 4 |
| 2026-09-01 | Couling John D | M (A) | 7,667 | $45.5 | 126,394 | Form 4 |
| 2026-09-01 | Couling John D | S (D) | 7,667 | $61.05 | 118,727 | Form 4 |
| 2026-08-28 | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 / Dolby Dagmar | G (D) | 300,000 | $0 | 0 | Form 4 |
| 2026-08-28 | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 / Dolby Dagmar | C (A) | 300,000 | $0 | 300,000 | Form 4 |
| 2026-08-25 | Nicholson Ryan | S (D) | 1,183 | $65.28 | 34,453 | Form 4 |
| 2026-08-14 | Revankar Shriram | S (D) | 3,000 | $62.71 | 73,274 | Form 4 |
| 2026-08-10 | Nicholson Ryan | S (D) | 1,348 | $62.04 | 35,636 | Form 4 |
| 2026-08-04 | Nicholson Ryan | S (D) | 357 | $60.63 | 36,984 | Form 4 |
| 2026-08-03 | Couling John D | S (D) | 783 | $59.03 | 125,611 | Form 4 |
| 2026-08-03 | Couling John D | M (A) | 7,667 | $45.5 | 126,394 | Form 4 |
| 2026-08-03 | Couling John D | S (D) | 6,884 | $60.11 | 118,727 | Form 4 |
| 2026-07-01 | Couling John D | S (D) | 7,667 | $53.2 | 118,727 | Form 4 |
| 2026-07-01 | Couling John D | M (A) | 7,667 | $45.5 | 126,394 | Form 4 |
Transaction codes in this quarter
Get DLB insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1308547&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · DLB company page · Dolby Laboratories, Inc. on SEC.gov
Questions
Are insiders buying or selling Dolby Laboratories, Inc. (DLB)?
In Q3 2026, insiders at Dolby Laboratories, Inc. reported 16 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $1.7M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Dolby Laboratories, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/dlb.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.